VBI Vaccines (VBV) News Today C$4.82 -0.26 (-5.12%) (As of 03/23/2018) Add Compare Share Share Headlines Stock Analysis All Sources Trusted Sources MarketBeat.com Benzinga Bloomberg GuruFocus MarketWatch Motley Fool NASDAQ PR Newswire Reuters Seeking Alpha The Street TipRanks The Wall Street Journal Yahoo Finance Source Sentiment refers to the positivity or negativity of each headline according to our language processing algorithm. Sentiment All Sentiments Very Positive Positive Neutral Negative Very Negative Most Recent November 2024 October 2024 September 2024 August 2024 July 2024 June 2024 May 2024 April 2024 March 2024 February 2024 January 2024 December 2023 November 2023 October 2023 September 2023 August 2023 July 2023 June 2023 May 2023 April 2023 March 2023 February 2023 January 2023 December 2022 November 2022 October 2022 September 2022 August 2022 July 2022 June 2022 May 2022 April 2022 March 2022 February 2022 January 2022 December 2021 Time Period Five Covid-19 vaccine false theories - debunkedOctober 26, 2024 | bbc.co.ukVBIVQ VBI Vaccines Inc.August 15, 2024 | seekingalpha.comVBI Vaccines Starts Restructuring Procedure in CanadaJuly 30, 2024 | marketwatch.comVBIV Stock Earnings: VBI Vaccines Beats EPS, Misses Revenue for Q4 2023April 16, 2024 | msn.comVBI Vaccines Inc VBIVOctober 31, 2023 | morningstar.comNo, Pfizer COVID-19 vaccine doesn't cause 'VAIDS.' That's not a real condition | Fact checkSeptember 26, 2023 | usatoday.comUpdated COVID-19 vaccine recommended for everyone; old, young, immunocompromised will benefit mostSeptember 23, 2023 | usatoday.comThe real data behind the new COVID vaccines the White House is pushingSeptember 21, 2023 | nypost.comCOVID vaccine pill that kills virus before it infects the body could be comingSeptember 15, 2023 | nypost.comBiden plans to ask Congress for funding to develop new COVID vaccine, may recommend shot for allAugust 30, 2023 | foxnews.comVBI Vaccines slides on discounted stock and warrants offeringJuly 6, 2023 | msn.comVBI Vaccines Shares Turn Lower, Erase After-Hours GainsJuly 5, 2023 | marketwatch.comVBI Vaccines gains ahead of upcoming presentation on hep B shotJune 7, 2023 | msn.comVBI Vaccines, Inc. (VBIV) Reports Q1 Loss, Misses Revenue EstimatesMay 15, 2023 | msn.comRaymond James Maintains VBI Vaccines (VBIV) Outperform RecommendationApril 14, 2023 | msn.comVBI Vaccines to Cut Workforce by 30%-35%, Focus on Hepatitis B >VBIVApril 5, 2023 | marketwatch.comVBI Vaccines Shares Plumb New Depths on Restructuring Plans >VBIVApril 5, 2023 | marketwatch.comVBI Vaccines to focus on hep B treatments, conduct 1-for-30 reverse stock splitApril 4, 2023 | msn.comHow mRNA vaccines could target everything from cancer to the plagueMarch 30, 2023 | nypost.comModerna CEO grilled over plan to raise Covid vaccine price at Senate hearingMarch 28, 2023 | nbcnews.comPeople without insurance will still get free COVID vaccines once government's supply runs outMarch 15, 2023 | usatoday.comFlorida surgeon general’s Covid vaccine claims harm public, health agencies sayMarch 14, 2023 | theguardian.comLA County eases COVID vaccine, testing restrictions as emergency declarations endMarch 13, 2023 | foxnews.comFlu vaccine was 68% effective at preventing hospitalization in children but less protective for seniors this seasonFebruary 24, 2023 | cnbc.comDevelop vaccines for all animal influenza strain, says incoming WHO chief scientistFebruary 22, 2023 | reuters.comPrior COVID infection provides just as much protection as vaccines, new study findsFebruary 22, 2023 | foxnews.comTwo Vaccines May Soon Shield Seniors Against RSVFebruary 20, 2023 | usnews.comThe Rise of Virus-like Particles (VLPs) Vaccine Market Research 2023-2029: Opportunities and ChallengesFebruary 15, 2023 | marketwatch.comAdvances and Growth Opportunities in RNA VaccinesFebruary 11, 2023 | finance.yahoo.comFDA vaccine panel to consider annual COVID shots: What we knowFebruary 9, 2023 | usatoday.comYearly COVID vaccine as proposed by FDA? 'Cart before the horse,' says doctorJanuary 26, 2023 | foxnews.comFDA proposes most Americans receive one annual COVID vaccine, similar to fluJanuary 25, 2023 | abcnews.go.comU.S. FDA proposes shift to annual COVID vaccine shotsJanuary 25, 2023 | reuters.comScientists Are Working on a COVID Vaccine You Can DrinkJanuary 24, 2023 | cnet.comRSV vaccine: Moderna, Pfizer start a new FDA approval raceJanuary 22, 2023 | cnbc.comCDC investigating whether Pfizer COVID vaccine increases stroke risk for people over 65January 16, 2023 | nypost.comVaccine Market Latest Trends 2023, Drivers, and Projections Report from 2023-2029| 101 Pages ReportJanuary 14, 2023 | marketwatch.comModerna under fire for 400% price hike of COVID vaccine: ‘Outrageous’January 14, 2023 | nypost.comPentagon officially rescinds COVID-19 vaccine mandateJanuary 13, 2023 | cbsnews.comPentagon ends COVID-19 vaccine mandate for US troopsJanuary 13, 2023 | nypost.comVLP Vaccines Market Global and Regional Analysis and Forecast 2028January 10, 2023 | marketwatch.comLooking Into VBI Vaccines's Return On Capital EmployedDecember 20, 2022 | msn.comVBI Vaccines Reports Third Quarter 2022 Financial Results and Provides Corporate UpdateNovember 10, 2022 | marketwatch.comFDA Approves Vaccine for Use During Third Trimester of Pregnancy to Prevent Whooping Cough in Infants Younger Than Two Months of AgeOctober 15, 2022 | finance.yahoo.comVBI Vaccines Secures $100 Million Debt Facility From K2 HealthVenturesSeptember 15, 2022 | finance.yahoo.comValneva and VBI Vaccines Announce European Partnership for Marketing and Distribution of PreHevbri(R)September 8, 2022 | barrons.comValneva and VBI Vaccines Announce European Partnership for Marketing and Distribution of PreHevbri®September 8, 2022 | tmcnet.comVBI Vaccines stock slumps 10% on Q2 miss, net loss widens on forex impactAugust 8, 2022 | seekingalpha.comVBI Vaccines gets FDA orphan drug designation for brain cancer vaccine candidate VBI-1901June 22, 2022 | seekingalpha.comVBI Vaccines hepatitis B shot PreHevbri gets approval in UKJune 1, 2022 | seekingalpha.com Get VBI Vaccines News Delivered to You Automatically Sign up to receive the latest news and ratings for VBV and its competitors with MarketBeat's FREE daily newsletter. Email Address Blackrock’s Sending THIS Crypto Higher on Purpose (Ad)It's a groundbreaking opportunity that could be poised for extraordinary gains. The catalyst behind this surge is a massive new blockchain development… YES, I WANT THE #1 CRYPTO NOW VBV Media Mentions By Week VBV Media Sentiment Learn about the media sentiment score. Each headline receives a score ranging from 2 (good news) to -2 (bad news). Our company news sentiment scores track the average news sentiment of articles about each company over the most recent 7 days in order to identify companies that are receiving positive press. VBV News Sentiment▼0.000.60▲Average Manufacturing News Sentiment VBV News Coverage Learn about the media coverage comparison. We track news headlines from hundreds of news outlets and tag them by company. This chart compares the number of articles about this company in the last seven days compared with the average number of articles about this company on a typical week. VBV Articles This Week▼00▲VBV Articles Average Week Get VBI Vaccines News Delivered to You Automatically Sign up to receive the latest news and ratings for VBV and its competitors with MarketBeat's FREE daily newsletter. Email Address Related Companies and Tools Related Companies CRON News Today SLS News Today APM News Today AIM News Today FRX News Today CRDL News Today ITH News Today MDNA News Today GXE News Today GPH News Today Headlines Tools Trending Media MentionsHigh Media Sentiment StocksLive News FeedMarketBeat OriginalsStock Ideas This page (TSE:VBV) was last updated on 11/4/2024 by MarketBeat.com Staff From Our Partners2 sentences that change everything you THOUGHT you knew about tradingIf you're like most people, on Friday morning you'll probably follow your set routine: Wake up... eat breakfas...Investing Daily | SponsoredBill Gates’s Next Big AI Bet: StargateIn February 2016… when almost nobody was talking about artificial intelligence…. I picked Nvidia as one of ...Brownstone Research | SponsoredElection warning coming true… If you missed it, my emergency election broadcast is now available - watch it before it's too late.Porter & Company | Sponsored625,000% GainImagine swapping your daily coffee expense for a future free of financial worries. It might seem far-fetche...Crypto Swap Profits | SponsoredA Totally New ‘Income Coin’Buckle up… Because this might shatter everything you thought you knew about "income trading." In fact, i...Crypto 101 Media | SponsoredThe centerpiece of Trump’s crypto’s masterplan …Donald Trump wants to be America’s first crypto president. He was the keynote speaker at the recent Bitcoin...Weiss Ratings | SponsoredA new way to play the AI boom (act before November 19)There's a new way to play the $15 trillion AI boom. And it's so simple - you can do it right now with as li...Behind the Markets | Sponsored Is Starlink Set For The Largest IPO In History?He turned PayPal from a tiny, off-the-radar startup… to a massive $64 billion giant. Then, he did it again ...Paradigm Press | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding VBI Vaccines Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share VBI Vaccines With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
